

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.03649586 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.03649586 |
| 3 | * sarcomere organization (GO:0045214) | 8.76038992 |
| 4 | cardiac myofibril assembly (GO:0055003) | 7.98098645 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.82097370 |
| 6 | myofibril assembly (GO:0030239) | 7.78224923 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 7.64332207 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.50827211 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.02813761 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.93836904 |
| 11 | plasma membrane repair (GO:0001778) | 6.67372702 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.63238325 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.50881587 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.47408173 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.04129606 |
| 16 | cardiac muscle cell development (GO:0055013) | 6.00511984 |
| 17 | striated muscle contraction (GO:0006941) | 5.95975692 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 5.90881947 |
| 19 | tricarboxylic acid cycle (GO:0006099) | 5.75773640 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.74534897 |
| 21 | * actomyosin structure organization (GO:0031032) | 5.70858015 |
| 22 | actin filament-based movement (GO:0030048) | 5.65374704 |
| 23 | cardiac cell development (GO:0055006) | 5.63597557 |
| 24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.46650617 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.46210377 |
| 26 | skeletal muscle contraction (GO:0003009) | 5.42575338 |
| 27 | carnitine shuttle (GO:0006853) | 5.40530710 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.36867556 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.32154166 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 5.31610878 |
| 31 | adult heart development (GO:0007512) | 5.29247336 |
| 32 | cardiac muscle hypertrophy (GO:0003300) | 5.26135095 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.21799617 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.21503112 |
| 35 | regulation of sarcomere organization (GO:0060297) | 5.10346426 |
| 36 | striated muscle hypertrophy (GO:0014897) | 5.07410978 |
| 37 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.03750201 |
| 38 | regulation of striated muscle contraction (GO:0006942) | 4.93016996 |
| 39 | muscle tissue morphogenesis (GO:0060415) | 4.91361923 |
| 40 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.82787859 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.77177963 |
| 42 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.75262408 |
| 43 | heart process (GO:0003015) | 4.73716966 |
| 44 | heart contraction (GO:0060047) | 4.73716966 |
| 45 | heart trabecula formation (GO:0060347) | 4.62663624 |
| 46 | fatty acid transmembrane transport (GO:1902001) | 4.61982718 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.55156010 |
| 48 | muscle hypertrophy (GO:0014896) | 4.47299400 |
| 49 | creatine metabolic process (GO:0006600) | 4.36503737 |
| 50 | skeletal muscle adaptation (GO:0043501) | 4.35493454 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 4.33229112 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 4.33229112 |
| 53 | muscle contraction (GO:0006936) | 4.20334527 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.18567071 |
| 55 | response to inactivity (GO:0014854) | 4.16747877 |
| 56 | regulation of the force of heart contraction (GO:0002026) | 4.15835047 |
| 57 | cell communication involved in cardiac conduction (GO:0086065) | 4.10946124 |
| 58 | striated muscle adaptation (GO:0014888) | 4.01232441 |
| 59 | carnitine transmembrane transport (GO:1902603) | 3.98909307 |
| 60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98337683 |
| 61 | striated muscle cell development (GO:0055002) | 3.93785312 |
| 62 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.92466669 |
| 63 | muscle hypertrophy in response to stress (GO:0003299) | 3.92466669 |
| 64 | cardiac muscle adaptation (GO:0014887) | 3.92466669 |
| 65 | skeletal muscle fiber development (GO:0048741) | 3.92424010 |
| 66 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.91970751 |
| 67 | negative regulation of protein localization to cell surface (GO:2000009) | 3.91164132 |
| 68 | muscle system process (GO:0003012) | 3.89911778 |
| 69 | cardiac muscle cell action potential (GO:0086001) | 3.80216071 |
| 70 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.79273767 |
| 71 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.77508767 |
| 72 | regulation of cardiac muscle contraction (GO:0055117) | 3.76573502 |
| 73 | negative regulation of potassium ion transport (GO:0043267) | 3.76327698 |
| 74 | cardiac chamber formation (GO:0003207) | 3.75932249 |
| 75 | myotube cell development (GO:0014904) | 3.74701355 |
| 76 | regulation of cardioblast differentiation (GO:0051890) | 3.70430009 |
| 77 | regulation of heart rate (GO:0002027) | 3.66693572 |
| 78 | regulation of ATP catabolic process (GO:1903289) | 3.64781059 |
| 79 | regulation of ATPase activity (GO:0043462) | 3.64781059 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.63201327 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.63201327 |
| 82 | amino-acid betaine transport (GO:0015838) | 3.63163375 |
| 83 | carnitine transport (GO:0015879) | 3.63163375 |
| 84 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.61661075 |
| 85 | regulation of muscle system process (GO:0090257) | 3.61031609 |
| 86 | striated muscle atrophy (GO:0014891) | 3.57884933 |
| 87 | cell communication by electrical coupling (GO:0010644) | 3.57637471 |
| 88 | skeletal muscle tissue development (GO:0007519) | 3.57375942 |
| 89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.57058154 |
| 90 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.57058154 |
| 91 | regulation of sulfur metabolic process (GO:0042762) | 3.53828041 |
| 92 | response to caffeine (GO:0031000) | 3.52861590 |
| 93 | response to muscle activity (GO:0014850) | 3.52841780 |
| 94 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51860937 |
| 95 | muscle fiber development (GO:0048747) | 3.50313820 |
| 96 | cardiac ventricle formation (GO:0003211) | 3.50191743 |
| 97 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.50189129 |
| 98 | ATP synthesis coupled proton transport (GO:0015986) | 3.50189129 |
| 99 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.48814767 |
| 100 | NADH metabolic process (GO:0006734) | 3.48546926 |
| 101 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.46080827 |
| 102 | muscle adaptation (GO:0043500) | 3.45464123 |
| 103 | glycogen catabolic process (GO:0005980) | 3.44982847 |
| 104 | muscle cell cellular homeostasis (GO:0046716) | 3.43912587 |
| 105 | respiratory electron transport chain (GO:0022904) | 3.43819672 |
| 106 | regulation of muscle contraction (GO:0006937) | 3.41445238 |
| 107 | relaxation of muscle (GO:0090075) | 3.40683349 |
| 108 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39923439 |
| 109 | oxidative phosphorylation (GO:0006119) | 3.39510441 |
| 110 | relaxation of cardiac muscle (GO:0055119) | 3.39399780 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 3.39209571 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.39165350 |
| 113 | muscle cell development (GO:0055001) | 3.38065596 |
| 114 | response to epinephrine (GO:0071871) | 3.37493825 |
| 115 | regulation of heart contraction (GO:0008016) | 3.36735224 |
| 116 | detection of calcium ion (GO:0005513) | 3.36188298 |
| 117 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.36124000 |
| 118 | glycogen biosynthetic process (GO:0005978) | 3.29104472 |
| 119 | glucan biosynthetic process (GO:0009250) | 3.29104472 |
| 120 | cellular response to epinephrine stimulus (GO:0071872) | 3.28766026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.88785036 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.67455827 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.96297857 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.89587738 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.89587738 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.76430894 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.61312981 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.37537989 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18736922 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.18644619 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.95524794 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.91229122 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.71621392 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63681123 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.38506079 |
| 16 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.18441527 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12296312 |
| 18 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.09044203 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.95378743 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.90232625 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84661138 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83945096 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73037434 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71430520 |
| 25 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.68684713 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59972615 |
| 27 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.58270279 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56761281 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48979629 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.41206168 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39245702 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37223466 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37032711 |
| 34 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34134345 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32511052 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31146614 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26030127 |
| 38 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.25752135 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25093616 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24033493 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22958916 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21447794 |
| 43 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20589176 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19746033 |
| 45 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19627061 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15986532 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15791365 |
| 48 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.15734478 |
| 49 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10689385 |
| 50 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09696137 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09301556 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08504708 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08291741 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06218347 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05266606 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04309900 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03908000 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03766614 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03758962 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02559055 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02311594 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02200528 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01861461 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01581988 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01093085 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00975176 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00848957 |
| 68 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00172504 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99574472 |
| 70 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98328819 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97944473 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97839270 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97825361 |
| 74 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97466374 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97353391 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96677424 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95406817 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95294593 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95125591 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94994319 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94603119 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94067092 |
| 83 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93110484 |
| 84 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.92844710 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91985487 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91897452 |
| 87 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91095964 |
| 88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89794056 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89739507 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88552583 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88375330 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88175845 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87143816 |
| 94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86812816 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85923811 |
| 96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85692144 |
| 97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85413839 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84971235 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84968512 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84307219 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83997933 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83862214 |
| 103 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83481220 |
| 104 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83000735 |
| 105 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82878548 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82123961 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82100874 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81983658 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81811394 |
| 110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81478994 |
| 111 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.80929320 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 0.80711920 |
| 113 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80216116 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80185697 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80161310 |
| 116 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80137039 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79531701 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78734045 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.78463408 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78278514 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78119151 |
| 122 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77895811 |
| 123 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.77887675 |
| 124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77514917 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77351394 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77198316 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.77196494 |
| 128 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77176770 |
| 129 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76501661 |
| 130 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76249449 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76244485 |
| 132 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75997322 |
| 133 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75997322 |
| 134 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.75492535 |
| 135 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75032209 |
| 136 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74840465 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74797278 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74745781 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74550156 |
| 140 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.74424898 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 0.73804906 |
| 142 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.72398144 |
| 143 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.72070218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.30254546 |
| 2 | MP0003646_muscle_fatigue | 5.71771768 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.29760576 |
| 4 | * MP0000751_myopathy | 4.94180600 |
| 5 | MP0000749_muscle_degeneration | 4.81083371 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.53896872 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.31168854 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.87830129 |
| 9 | * MP0005330_cardiomyopathy | 3.54538448 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.34767319 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.10498024 |
| 12 | MP0005620_abnormal_muscle_contractility | 3.05796172 |
| 13 | * MP0002106_abnormal_muscle_physiology | 3.04864240 |
| 14 | MP0002972_abnormal_cardiac_muscle | 3.01034622 |
| 15 | MP0004130_abnormal_muscle_cell | 2.74379535 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.65588243 |
| 17 | * MP0002269_muscular_atrophy | 2.53127342 |
| 18 | * MP0005369_muscle_phenotype | 2.49108591 |
| 19 | * MP0000759_abnormal_skeletal_muscle | 2.47102674 |
| 20 | * MP0000747_muscle_weakness | 2.45487783 |
| 21 | * MP0010630_abnormal_cardiac_muscle | 2.43136478 |
| 22 | * MP0003137_abnormal_impulse_conducting | 2.42709536 |
| 23 | MP0004484_altered_response_of | 2.32558969 |
| 24 | * MP0005385_cardiovascular_system_phenoty | 2.31258582 |
| 25 | * MP0001544_abnormal_cardiovascular_syste | 2.31258582 |
| 26 | MP0006138_congestive_heart_failure | 2.14620686 |
| 27 | MP0004233_abnormal_muscle_weight | 2.03018995 |
| 28 | MP0003828_pulmonary_edema | 2.02758446 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.91589441 |
| 30 | MP0004085_abnormal_heartbeat | 1.88238572 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.80385396 |
| 32 | MP0004510_myositis | 1.72901324 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.72546044 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.59908521 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.59890342 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.41235883 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27415429 |
| 38 | MP0000733_abnormal_muscle_development | 1.23485762 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.22410502 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.15752479 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.12866383 |
| 42 | * MP0000266_abnormal_heart_morphology | 1.07347086 |
| 43 | MP0005670_abnormal_white_adipose | 1.06480912 |
| 44 | MP0000343_altered_response_to | 1.01728304 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.00288357 |
| 46 | MP0001661_extended_life_span | 0.99665433 |
| 47 | MP0005375_adipose_tissue_phenotype | 0.98876170 |
| 48 | MP0003279_aneurysm | 0.91950775 |
| 49 | MP0010368_abnormal_lymphatic_system | 0.87282799 |
| 50 | MP0005165_increased_susceptibility_to | 0.86895045 |
| 51 | MP0005266_abnormal_metabolism | 0.85669558 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.80680907 |
| 53 | MP0002971_abnormal_brown_adipose | 0.76557772 |
| 54 | MP0005623_abnormal_meninges_morphology | 0.75361361 |
| 55 | MP0002128_abnormal_blood_circulation | 0.73363662 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.70779792 |
| 57 | MP0003566_abnormal_cell_adhesion | 0.70745584 |
| 58 | MP0005451_abnormal_body_composition | 0.70515777 |
| 59 | MP0005275_abnormal_skin_tensile | 0.68224511 |
| 60 | MP0000013_abnormal_adipose_tissue | 0.68047963 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.66838573 |
| 62 | MP0004043_abnormal_pH_regulation | 0.60096107 |
| 63 | MP0004272_abnormal_basement_membrane | 0.60069825 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.59007910 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.54406439 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 0.54306010 |
| 67 | MP0000767_abnormal_smooth_muscle | 0.53938574 |
| 68 | MP0004147_increased_porphyrin_level | 0.52418942 |
| 69 | MP0002822_catalepsy | 0.49600544 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.45533306 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.44877624 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.43098097 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.42316884 |
| 74 | MP0008961_abnormal_basal_metabolism | 0.39994754 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.39986559 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.39813761 |
| 77 | MP0005187_abnormal_penis_morphology | 0.38528781 |
| 78 | MP0001784_abnormal_fluid_regulation | 0.37869702 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.36089677 |
| 80 | * MP0001614_abnormal_blood_vessel | 0.31330021 |
| 81 | MP0005334_abnormal_fat_pad | 0.31291689 |
| 82 | MP0001984_abnormal_olfaction | 0.31059687 |
| 83 | MP0003045_fibrosis | 0.30678142 |
| 84 | MP0003984_embryonic_growth_retardation | 0.30060860 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.29357185 |
| 86 | * MP0003948_abnormal_gas_homeostasis | 0.29049000 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.28710194 |
| 88 | MP0003879_abnormal_hair_cell | 0.27154259 |
| 89 | MP0001299_abnormal_eye_distance/ | 0.27082210 |
| 90 | MP0004134_abnormal_chest_morphology | 0.26535197 |
| 91 | MP0005535_abnormal_body_temperature | 0.26526963 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.26146979 |
| 93 | MP0005503_abnormal_tendon_morphology | 0.25980669 |
| 94 | MP0004924_abnormal_behavior | 0.24552409 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.24552409 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.23229508 |
| 97 | MP0005452_abnormal_adipose_tissue | 0.23215981 |
| 98 | MP0009115_abnormal_fat_cell | 0.22382391 |
| 99 | MP0000762_abnormal_tongue_morphology | 0.22312964 |
| 100 | MP0000579_abnormal_nail_morphology | 0.21820627 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.21113699 |
| 102 | MP0005423_abnormal_somatic_nervous | 0.19670691 |
| 103 | MP0004142_abnormal_muscle_tone | 0.19113920 |
| 104 | MP0006276_abnormal_autonomic_nervous | 0.18768823 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.18736055 |
| 106 | MP0009250_abnormal_appendicular_skeleto | 0.18533513 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.18224796 |
| 108 | MP0008569_lethality_at_weaning | 0.17974144 |
| 109 | MP0002114_abnormal_axial_skeleton | 0.17328015 |
| 110 | MP0001958_emphysema | 0.16255076 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.16206375 |
| 112 | MP0004270_analgesia | 0.16136274 |
| 113 | MP0005332_abnormal_amino_acid | 0.16006218 |
| 114 | MP0003941_abnormal_skin_development | 0.15853115 |
| 115 | MP0008004_abnormal_stomach_pH | 0.15839847 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.15791460 |
| 117 | MP0003385_abnormal_body_wall | 0.15470005 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.14646177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.38653077 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.17362936 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 7.01071233 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.86359241 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.70063104 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.86403508 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 5.56033310 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.53201885 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.42932847 |
| 10 | Subaortic stenosis (HP:0001682) | 5.34757804 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.34757804 |
| 12 | Myoglobinuria (HP:0002913) | 5.14223741 |
| 13 | * Muscle fiber splitting (HP:0003555) | 5.00002792 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 4.95434910 |
| 15 | Atrial fibrillation (HP:0005110) | 4.94189506 |
| 16 | Nemaline bodies (HP:0003798) | 4.73679474 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 4.61084291 |
| 18 | * Hyporeflexia of lower limbs (HP:0002600) | 4.60961315 |
| 19 | Difficulty running (HP:0009046) | 4.51070321 |
| 20 | Supraventricular tachycardia (HP:0004755) | 4.45001340 |
| 21 | * Lipoatrophy (HP:0100578) | 4.43826935 |
| 22 | * EMG: myopathic abnormalities (HP:0003458) | 4.40716730 |
| 23 | Increased connective tissue (HP:0009025) | 4.38989829 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.36735072 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.36531406 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.06749033 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 4.05085630 |
| 28 | Syncope (HP:0001279) | 4.03829664 |
| 29 | Dilated cardiomyopathy (HP:0001644) | 3.92564765 |
| 30 | Myotonia (HP:0002486) | 3.88041177 |
| 31 | Bundle branch block (HP:0011710) | 3.76897227 |
| 32 | Prolonged QT interval (HP:0001657) | 3.75988959 |
| 33 | Distal arthrogryposis (HP:0005684) | 3.70059352 |
| 34 | Palpitations (HP:0001962) | 3.69333966 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.38374625 |
| 36 | Muscle stiffness (HP:0003552) | 3.36119697 |
| 37 | Round ear (HP:0100830) | 3.31302708 |
| 38 | * Ventricular arrhythmia (HP:0004308) | 3.26169030 |
| 39 | Neck muscle weakness (HP:0000467) | 3.22290352 |
| 40 | Myopathic facies (HP:0002058) | 3.20664806 |
| 41 | Heart block (HP:0012722) | 3.19440463 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.09369017 |
| 43 | Ventricular fibrillation (HP:0001663) | 3.08924546 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.05739111 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 3.02124257 |
| 46 | Atrioventricular block (HP:0001678) | 3.00871688 |
| 47 | Areflexia of lower limbs (HP:0002522) | 2.82658305 |
| 48 | Rimmed vacuoles (HP:0003805) | 2.72558579 |
| 49 | Abnormal EKG (HP:0003115) | 2.72418385 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.69213005 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.68348435 |
| 52 | Abnormal finger flexion creases (HP:0006143) | 2.60038112 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.55556511 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.37845425 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.35898657 |
| 56 | Gowers sign (HP:0003391) | 2.34573846 |
| 57 | Limb-girdle muscle atrophy (HP:0003797) | 2.34029961 |
| 58 | Hypoplastic ischia (HP:0003175) | 2.33792275 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33413590 |
| 60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33030429 |
| 61 | Muscular dystrophy (HP:0003560) | 2.30785591 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.28082053 |
| 63 | Weak cry (HP:0001612) | 2.26389130 |
| 64 | Scapular winging (HP:0003691) | 2.24692497 |
| 65 | Hepatic necrosis (HP:0002605) | 2.22558171 |
| 66 | * Left ventricular hypertrophy (HP:0001712) | 2.22199925 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.22057576 |
| 68 | * Palmoplantar keratoderma (HP:0000982) | 2.20325500 |
| 69 | Calcaneovalgus deformity (HP:0001848) | 2.17559946 |
| 70 | Frequent falls (HP:0002359) | 2.17147134 |
| 71 | Facial diplegia (HP:0001349) | 2.14413133 |
| 72 | Ketoacidosis (HP:0001993) | 2.13624176 |
| 73 | Abnormality of the foot musculature (HP:0001436) | 2.10469376 |
| 74 | Absent phalangeal crease (HP:0006109) | 2.07580781 |
| 75 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04109362 |
| 76 | Abnormality of the ischium (HP:0003174) | 2.03251377 |
| 77 | Conjunctival hamartoma (HP:0100780) | 1.98519170 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 1.98287938 |
| 79 | Foot dorsiflexor weakness (HP:0009027) | 1.97345937 |
| 80 | Testicular atrophy (HP:0000029) | 1.96049971 |
| 81 | Proximal amyotrophy (HP:0007126) | 1.94986413 |
| 82 | Deformed tarsal bones (HP:0008119) | 1.94854199 |
| 83 | Acute encephalopathy (HP:0006846) | 1.94633246 |
| 84 | Exercise intolerance (HP:0003546) | 1.94488650 |
| 85 | Hepatocellular necrosis (HP:0001404) | 1.93945643 |
| 86 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93857167 |
| 87 | Waddling gait (HP:0002515) | 1.93519870 |
| 88 | Hypoglycemic coma (HP:0001325) | 1.93072858 |
| 89 | Abnormality of the calcaneus (HP:0008364) | 1.92338671 |
| 90 | Increased muscle lipid content (HP:0009058) | 1.91464557 |
| 91 | Progressive macrocephaly (HP:0004481) | 1.87114595 |
| 92 | Spinal rigidity (HP:0003306) | 1.85583172 |
| 93 | Hip contracture (HP:0003273) | 1.85510131 |
| 94 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85359443 |
| 95 | Malignant hyperthermia (HP:0002047) | 1.83571049 |
| 96 | Limb-girdle muscle weakness (HP:0003325) | 1.83302734 |
| 97 | Hyperkalemia (HP:0002153) | 1.82216308 |
| 98 | Mitochondrial inheritance (HP:0001427) | 1.81731092 |
| 99 | Fatigable weakness (HP:0003473) | 1.81245382 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 1.81245382 |
| 101 | Steppage gait (HP:0003376) | 1.78694727 |
| 102 | Slender build (HP:0001533) | 1.76944090 |
| 103 | * EMG: neuropathic changes (HP:0003445) | 1.76801988 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 1.75320061 |
| 105 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75320061 |
| 106 | Bulbar palsy (HP:0001283) | 1.74058296 |
| 107 | Lower limb amyotrophy (HP:0007210) | 1.73610598 |
| 108 | Increased CSF lactate (HP:0002490) | 1.73085015 |
| 109 | Cerebral edema (HP:0002181) | 1.72452245 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71844670 |
| 111 | Popliteal pterygium (HP:0009756) | 1.70607715 |
| 112 | Hypoplastic heart (HP:0001961) | 1.67577204 |
| 113 | Limited hip movement (HP:0008800) | 1.65165906 |
| 114 | Aplasia of the musculature (HP:0100854) | 1.57011593 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.54953546 |
| 116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.51226933 |
| 117 | Metatarsus adductus (HP:0001840) | 1.48127114 |
| 118 | Dysmetric saccades (HP:0000641) | 1.37273709 |
| 119 | * Sudden cardiac death (HP:0001645) | 1.37088822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.57408162 |
| 2 | TTN | 6.10667788 |
| 3 | PHKG2 | 4.57113661 |
| 4 | PHKG1 | 4.57113661 |
| 5 | DMPK | 3.08902930 |
| 6 | PDK3 | 3.03290071 |
| 7 | PDK4 | 3.03290071 |
| 8 | MYLK | 2.95458535 |
| 9 | LMTK2 | 2.81033177 |
| 10 | PKN2 | 2.64660135 |
| 11 | TRIB3 | 2.54475905 |
| 12 | NEK1 | 2.31197575 |
| 13 | PIK3CA | 2.30844578 |
| 14 | MUSK | 2.26265990 |
| 15 | STK24 | 2.01746430 |
| 16 | BCKDK | 1.96196497 |
| 17 | PINK1 | 1.93354577 |
| 18 | PDK2 | 1.84850932 |
| 19 | TIE1 | 1.70455465 |
| 20 | NME1 | 1.54044038 |
| 21 | PIK3CG | 1.53543191 |
| 22 | MARK1 | 1.47947806 |
| 23 | MAP3K7 | 1.45800580 |
| 24 | MAP2K3 | 1.36719933 |
| 25 | MAPK12 | 1.25003487 |
| 26 | ILK | 1.24583082 |
| 27 | ZAK | 1.16397369 |
| 28 | PRKD1 | 1.07148999 |
| 29 | CAMK2D | 1.06805963 |
| 30 | PAK3 | 1.06349711 |
| 31 | TRPM7 | 0.94181427 |
| 32 | MAPKAPK3 | 0.93296061 |
| 33 | GRK7 | 0.92871604 |
| 34 | ROCK1 | 0.91310601 |
| 35 | PRKAA2 | 0.90774979 |
| 36 | PRKAA1 | 0.88765537 |
| 37 | CDC42BPA | 0.88390733 |
| 38 | EEF2K | 0.85724720 |
| 39 | INSRR | 0.83383839 |
| 40 | RIPK1 | 0.83136441 |
| 41 | MAP3K5 | 0.80563524 |
| 42 | WNK4 | 0.77900233 |
| 43 | MAP3K3 | 0.71433956 |
| 44 | PKN1 | 0.70480409 |
| 45 | STK38L | 0.68807549 |
| 46 | CCNB1 | 0.66208108 |
| 47 | EPHB1 | 0.65765894 |
| 48 | FLT3 | 0.64966699 |
| 49 | MAPK4 | 0.62623574 |
| 50 | STK4 | 0.61387214 |
| 51 | DAPK3 | 0.61116084 |
| 52 | PDGFRA | 0.59171972 |
| 53 | CAMK2B | 0.56984844 |
| 54 | MOS | 0.56052848 |
| 55 | WNK1 | 0.54804632 |
| 56 | ROCK2 | 0.54655897 |
| 57 | ERBB3 | 0.54532878 |
| 58 | EPHA3 | 0.52274268 |
| 59 | MAP2K4 | 0.51671906 |
| 60 | CAMK4 | 0.50276610 |
| 61 | NEK9 | 0.49801770 |
| 62 | DYRK1B | 0.49315354 |
| 63 | PTK2B | 0.49085361 |
| 64 | CAMK2A | 0.48263987 |
| 65 | MAP3K6 | 0.47213873 |
| 66 | AKT2 | 0.46752988 |
| 67 | PRKACB | 0.46655442 |
| 68 | CAMK2G | 0.45439291 |
| 69 | SIK1 | 0.44732627 |
| 70 | STK38 | 0.44420870 |
| 71 | ICK | 0.42627542 |
| 72 | STK39 | 0.41975452 |
| 73 | TGFBR2 | 0.40991391 |
| 74 | PTK6 | 0.39886304 |
| 75 | CAMK1 | 0.39343308 |
| 76 | MAP2K6 | 0.39191486 |
| 77 | KSR2 | 0.38692717 |
| 78 | KDR | 0.36901338 |
| 79 | PRKACA | 0.36050448 |
| 80 | SGK2 | 0.32285522 |
| 81 | RPS6KL1 | 0.32048695 |
| 82 | RPS6KC1 | 0.32048695 |
| 83 | PDPK1 | 0.31614076 |
| 84 | LIMK1 | 0.30425051 |
| 85 | PRKACG | 0.29087371 |
| 86 | LATS1 | 0.28179060 |
| 87 | PRKG1 | 0.26161983 |
| 88 | MAPK10 | 0.25647700 |
| 89 | MAPK11 | 0.25135912 |
| 90 | RPS6KA6 | 0.25034097 |
| 91 | PDK1 | 0.24919503 |
| 92 | PRKCE | 0.24225870 |
| 93 | LATS2 | 0.22132189 |
| 94 | FER | 0.21290761 |
| 95 | EPHB2 | 0.20898952 |
| 96 | UHMK1 | 0.20749168 |
| 97 | MTOR | 0.20062512 |
| 98 | MAP3K10 | 0.19940672 |
| 99 | TAOK1 | 0.19827147 |
| 100 | SGK1 | 0.19443311 |
| 101 | PRKD3 | 0.19172660 |
| 102 | MAPK7 | 0.18415763 |
| 103 | STK11 | 0.18386846 |
| 104 | MARK2 | 0.18107086 |
| 105 | PRKCH | 0.17878601 |
| 106 | RPS6KA3 | 0.17587513 |
| 107 | RPS6KA1 | 0.17323560 |
| 108 | RET | 0.15736111 |
| 109 | RPS6KB2 | 0.15275771 |
| 110 | SGK494 | 0.15236782 |
| 111 | SGK223 | 0.15236782 |
| 112 | MAP3K11 | 0.15077510 |
| 113 | NLK | 0.14187280 |
| 114 | MAP3K13 | 0.14144748 |
| 115 | PRKG2 | 0.13514538 |
| 116 | PAK6 | 0.12956131 |
| 117 | MAP3K1 | 0.12475143 |
| 118 | SGK3 | 0.11340730 |
| 119 | DDR2 | 0.10169040 |
| 120 | LRRK2 | 0.09526618 |
| 121 | RPS6KB1 | 0.09099571 |
| 122 | MAPK13 | 0.07900597 |
| 123 | CDK5 | 0.07097835 |
| 124 | MAP2K1 | 0.06593881 |
| 125 | RPS6KA2 | 0.06190762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.60889623 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.48023733 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.15973696 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.08385765 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.06843607 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.98241219 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.92352111 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89463906 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.88471838 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.75353924 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50352689 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.35599671 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.19907420 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.00206062 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.96329280 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94629103 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89553992 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.81256713 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.70964432 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.65080019 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42019860 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.39554456 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.29576351 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.29459321 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28043946 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19218366 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17519203 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14762827 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12849318 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11545764 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07847965 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03576634 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97785852 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 0.93683128 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92644271 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 0.92256488 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89471301 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88235667 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81948895 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81824639 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81123632 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75639932 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71461279 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65949365 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65849219 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62694803 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62319674 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61730376 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.61444539 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61272037 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60582992 |
| 52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59207307 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58260647 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56672751 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55749348 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.55526725 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53500811 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53149256 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51650179 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51036306 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.50628584 |
| 62 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48084465 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45556199 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.44735448 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.41311857 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40848119 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39854186 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37778256 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36250817 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34816491 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34543499 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34536306 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33902993 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.33398906 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33187483 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.31513642 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29474914 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29473117 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29311875 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.29296383 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.27215706 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26864867 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26699923 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25022121 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24987846 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23980182 |
| 87 | Olfactory transduction_Homo sapiens_hsa04740 | 0.22052806 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.20640996 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20529876 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.20055688 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18716158 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17088206 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16260920 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16111572 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15903496 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15032212 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.14822644 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14701725 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.13851070 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13274159 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12926643 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.12343229 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11008377 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.09031298 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.08886159 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.08829191 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08330278 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.08054887 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.07758574 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.04213423 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03321033 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.03193024 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03072523 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02022348 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.01863219 |

